Veeva Announces Fiscal 2026 First Quarter Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/5/2026
- Equities close higher as softer jobs data quiets rate-hike expectations
- U.S. economy adds fewer jobs than expected as unemployment rate ticks higher
- Nvidia returns as Morgan Stanley’s Top Pick on attractive valuation
- Citi says rate volatility without Fed repricing is concerning
- U.S. credit-reporting stocks fall as FHFA weighs two-bureau mortgage rule
- Equities close higher as softer jobs data quiets rate-hike expectations
- Cantor Fitzgerald on Rivian (RIVN): 'pre-announced that it delivered 19,248 vehicles in 3Q26, above our estimate'
- DISH DBS emerges from bankruptcy, cuts debt by $4.35 billion
- Nvidia returns as Morgan Stanley’s Top Pick on attractive valuation
- Tanker struck by projectile in Strait of Hormuz
Veeva Systems (VEEV) PT Raised to $304 at BofA Securities
May 29, 2025 5:38 AM EDTBofA Securities analyst Brad Sills raised the price target on Veeva Systems (NYSE: VEEV) to $304.00 (from $254.00) while maintaining a Neutral rating.
The analyst comments "Veeva reported a strong start to FY26, with subscription revenue and normalized billings of $635 million (+19% y/y) and $714... More
Veeva Systems (VEEV) PT Raised to $295 at Stifel
May 29, 2025 5:05 AM EDTStifel analyst David Grossman raised the price target on Veeva Systems (NYSE: VEEV) to $295.00 (from $272.00) while maintaining a Buy rating.
The analyst comments "F1Q revenue significantly outperformed (subscription revenue +19%, +17% total revenue growth), which translated to meaningful billings/margin/EPS outperformance. Both subscription (+19% y/y, 85% of... More
Veeva Systems (VEEV) PT Raised to $210 at Morgan Stanley
May 29, 2025 5:02 AM EDTMorgan Stanley analyst Craig Hettenbach raised the price target on Veeva Systems (NYSE: VEEV) to $210.00 (from $201.00) while maintaining a Underweight rating.
The analyst comments "Why stay Underweight? Veeva deserves credit for navigating through a tumultuous backdrop in Life Sciences that has tripped up... More
